Page last updated: 2024-08-22

trimetazidine and Choroid Neovascularization

trimetazidine has been researched along with Choroid Neovascularization in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourgeois, H; Chaine, G; Cohen, SY; Corbe, C; Espinasse-Berrod, MA; Garcia-Sanchez, J; Gaudric, A; Hullo, A; Leys, A; Sahel, J; Soubrane, G	1

Trials

1 trial(s) available for trimetazidine and Choroid Neovascularization

Article	Year
Randomized clinical trial France DMLA2: effect of trimetazidine on exudative and nonexudative age-relatedmacular degeneration. Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:4 Topics: Aged; Aged, 80 and over; Belgium; Choroidal Neovascularization; Double-Blind Method; Exudates and Transudates; Female; Follow-Up Studies; France; Humans; Macular Degeneration; Male; Middle Aged; Spain; Trimetazidine; Vasodilator Agents	2012

Article

Year

Randomized clinical trial France DMLA2: effect of trimetazidine on exudative and nonexudative age-relatedmacular degeneration.

Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:4

Topics: Aged; Aged, 80 and over; Belgium; Choroidal Neovascularization; Double-Blind Method; Exudates and Transudates; Female; Follow-Up Studies; France; Humans; Macular Degeneration; Male; Middle Aged; Spain; Trimetazidine; Vasodilator Agents

2012